Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
|Articles|May 19, 2022
Daily OTC Pearl: Leg Cramp Relief
Author(s)Saro Arakelians, PharmD
OTC leg cramp medications may help with pain caused by cramping in the calf and foot.
Advertisement
OTC/Lifestyle Pearl of the Day: Leg Cramp Relief
Indication: OTC leg cramp medications can help with pain caused by cramping in the calf and foot.
Insight:
- Ingredients: Calcarea carbonica 12X HPUS, causticum 12X HPUS, chamomilla 6X HPUS, cinchona officinalis 3X HPUS, cuprum metallicum 12X HPUS, lycopodium 12X HPUS, magnesia phosphorica 6X HPUS, rhus toxicodendron 6X HPUS, silicea 12X HPUS, sulphur 6X HPUS.
- Helps relax calf and foot cramps.
- Homeopathic medication.
- Dissolve 2 to 3 tablets under the tongue before bedtime.
Source:
Advertisement
Related to this article
In a Pharmacy Times interview, study coauthor William J. Peppard, PharmD, discusses the association between suzetrigine and fewer opioid refills after knee replacement, the limits of the evidence, and the access barriers pharmacists can help patients navigate.
Novo's topline phase 3 data show 12.4% weight loss with CagriSema 1.0 mg/1.0 mg in type 2 diabetes and 21.0% in adults with overweight or obesity.
Researchers found substantial overlap in autonomic symptoms, orthostatic tachycardia, and functional impairment between long COVID and POTS.
A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
Insulin efsitora alfa-gobe (Onswik; Eli Lilly and Company) is designed to deliver steady basal insulin levels over a full 7-day duration.
Vallerie McLaughlin, MD, explains why the ERS update strongly recommends sotatercept for patients with pulmonary arterial hypertension (PAH) who don't reach low-risk status on initial therapy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ramantamig's 93.6% ORR and Outpatient CRS Control
2
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
3
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
4
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
5